| scholarly article | Q13442814 |
| P50 | author | Satoru Nagase | Q64684685 |
| Megan Keniry | Q89367043 | ||
| P2093 | author name string | Ramon Parsons | |
| Hanina Hibshoosh | |||
| Tao Su | |||
| Wei Xia | |||
| Lorenzo Memeo | |||
| Sergey M Kalachikov | |||
| Amy Gerstein Montia | |||
| P2860 | cites work | The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes | Q24290517 |
| Selectivity of chromatin-remodelling cofactors for ligand-activated transcription | Q24292110 | ||
| PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes | Q24306301 | ||
| Purification and biochemical heterogeneity of the mammalian SWI-SNF complex | Q24316969 | ||
| The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest | Q24321861 | ||
| A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex | Q24551058 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines | Q28138156 | ||
| Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator | Q28202210 | ||
| Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15 | Q28239045 | ||
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer | Q28277002 | ||
| Polybromo protein BAF180 functions in mammalian cardiac chamber maturation | Q28591027 | ||
| Requirement for p53 and p21 to sustain G2 arrest after DNA damage | Q29547667 | ||
| dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data | Q30899629 | ||
| Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. | Q34202062 | ||
| Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism | Q34235866 | ||
| Cloning the differences between two complex genomes | Q34360785 | ||
| The RB and p53 pathways in cancer | Q34804764 | ||
| BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. | Q35545332 | ||
| The SWI/SNF complex--chromatin and cancer. | Q35667471 | ||
| Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. | Q36791514 | ||
| Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells | Q38343246 | ||
| TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b | Q39420254 | ||
| Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells | Q40351489 | ||
| Role for BRG1 in cell cycle control and tumor suppression | Q40376914 | ||
| Both PPARgamma and PPARdelta influence sulindac sulfide-mediated p21WAF1/CIP1 upregulation in a human prostate epithelial cell line. | Q40386873 | ||
| Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene | Q40529870 | ||
| Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. | Q40870310 | ||
| Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation | Q41145746 | ||
| Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant | Q42546942 | ||
| Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. | Q44083876 | ||
| Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage | Q59098609 | ||
| Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability | Q81662165 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1667-1674 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer | |
| P478 | volume | 68 |
| Q38717620 | A genetic interaction analysis identifies cancer drivers that modify EGFR dependency |
| Q33891958 | A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex |
| Q39341270 | A role for chromatin remodellers in replication of damaged DNA. |
| Q28292188 | A secreted PTEN phosphatase that enters cells to alter signaling and survival |
| Q26849467 | ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy |
| Q34627244 | ATP-dependent chromatin remodeling: genetics, genomics and mechanisms |
| Q36111466 | An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC). |
| Q38786462 | BAF180 promotes cohesion and prevents genome instability and aneuploidy |
| Q37190016 | BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21 |
| Q38545726 | BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies |
| Q36788045 | BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene. |
| Q37995720 | Cancer and the bromodomains of BAF180. |
| Q38150651 | Cancer genomics identifies disrupted epigenetic genes |
| Q38058125 | Chromatin regulators with tumor suppressor properties and their alterations in human cancers |
| Q33907067 | Chromatin-regulating proteins as targets for cancer therapy |
| Q37627446 | Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma. |
| Q35640108 | Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma |
| Q27728041 | Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis |
| Q37970954 | Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer |
| Q41875235 | Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment |
| Q38639828 | Driver mutations of cancer epigenomes. |
| Q34452365 | E2F6 associates with BRG1 in transcriptional regulation |
| Q37976256 | Epigenetic regulation in RCC: opportunities for therapeutic intervention? |
| Q39456766 | Epigenomic Consequences of Coding and Noncoding Driver Mutations |
| Q38709544 | Epigenomic regulation of oncogenesis by chromatin remodeling |
| Q35762971 | Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression |
| Q24337664 | Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma |
| Q24319845 | FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus |
| Q34260197 | Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids |
| Q41703426 | Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours |
| Q42365306 | Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression |
| Q33709786 | Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA |
| Q57754675 | Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population |
| Q37618471 | Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer |
| Q37414110 | Histone modifications: implications in renal cell carcinoma |
| Q35530169 | Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells |
| Q34159629 | IL-10 transcription is negatively regulated by BAF180, a component of the SWI/SNF chromatin remodeling enzyme |
| Q41857096 | Induction of functional Brm protein from Brm knockout mice |
| Q64084325 | Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1 |
| Q34566605 | Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations |
| Q39949572 | Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. |
| Q36095258 | Low PBRM1 identifies tumor progression and poor prognosis in breast cancer |
| Q34332647 | Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. |
| Q33729097 | Molecular genetics of clear-cell renal cell carcinoma |
| Q34480997 | Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells |
| Q93379768 | Mutations in renal cell carcinoma |
| Q92854022 | New Insights into the Role of Polybromo-1 in Prostate Cancer |
| Q92381563 | Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle |
| Q37389731 | Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. |
| Q38852640 | PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas |
| Q64085735 | PBRM1 Regulates Stress Response in Epithelial Cells |
| Q35995926 | PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma |
| Q38122565 | PBRM1 and BAP1 as novel targets for renal cell carcinoma |
| Q41532653 | PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway |
| Q41931705 | PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer. |
| Q36140798 | PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest |
| Q53089460 | Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma. |
| Q37107294 | Polybromo-1: the chromatin targeting subunit of the PBAF complex |
| Q34069831 | Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence |
| Q92154621 | Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma |
| Q33699134 | Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism |
| Q38083797 | Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer |
| Q21134718 | SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes |
| Q26998657 | SWI/SNF chromatin remodeling complexes and cancer |
| Q33923821 | SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma |
| Q37886668 | SWI/SNF nucleosome remodellers and cancer. |
| Q35592205 | SWItching on the transcriptional circuitry in melanoma |
| Q37100131 | Somatic alterations contributing to metastasis of a castration-resistant prostate cancer |
| Q41039086 | Stability of the PHF10 subunit of PBAF signature module is regulated by phosphorylation: role of β-TrCP. |
| Q27660428 | Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2 |
| Q35369863 | TCR-dependent transformation of mature memory phenotype T cells in mice |
| Q42022357 | Target genes of the largest human SWI/SNF complex subunit control cell growth. |
| Q45880509 | Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development. |
| Q27679325 | The BAH domain of Rsc2 is a histone H3 binding domain |
| Q33683959 | The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma |
| Q28292392 | The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases |
| Q36872295 | The VHL/HIF axis in clear cell renal carcinoma |
| Q36642885 | The clinical significance of SWI/SNF complex in pancreatic cancer |
| Q38826541 | The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex |
| Q51091490 | The epigenetic landscape of clear-cell renal cell carcinoma. |
| Q39021700 | The epigenetic landscape of renal cancer |
| Q37603631 | The role of maintenance proteins in the preservation of epithelial cell identity during mammary gland remodeling and breast cancer initiation |
| Q28083152 | The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer |
| Q21090801 | The spectrum of SWI/SNF mutations, ubiquitous in human cancers |
| Q34168539 | The two different isoforms of the RSC chromatin remodeling complex play distinct roles in DNA damage responses |
| Q39005896 | Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. |
| Q36846013 | Two subunits specific to the PBAP chromatin remodeling complex have distinct and redundant functions during drosophila development. |
Search more.